COMP <GO>
GENI vs PG // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Genius Sports Limited (NYSE) VS. Procter & Gamble Company (NYSE) • 15-METRIC TALLY: GENI 1
— PG 10
■ METRIC PARITY
LAST: $6.46 (+1.73%) • MKT CAP: $1.73B
options-implied-move
—
LAST: $160.59 (+1.47%) • MKT CAP: $372.21B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GENI VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GENI | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 23.00% | 51.20% | -28.20 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -26.90% | 25.40% | -52.30 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 16.2x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 3.73% | 3.77% | -0.04 | PG | /fcf-yield <GO> |
| Operating Margin | -22.60% | 24.30% | -46.90 | PG | /operating-margins <GO> |
| Net Profit Margin | -16.70% | 19.00% | -35.70 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 31.00% | 0.30% | +30.70 | GENI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.43 | 5.59 | -4.16 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | PG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.2 | 60.3 | -12.14 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.87 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 21.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.73B | $372.21B | -$370.48B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GENI REV | PG REV | GENI GROSS % | PG GROSS % | GENI FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $669.5M | $84.28B | 23.0% | 51.2% | $64.5M | $14.04B |
| FY 2024 | $510.9M | $84.04B | 25.2% | 51.4% | $69.6M | $16.52B |
| FY 2023 | $413.0M | $82.01B | — | — | $14.9M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GENI // BETA —
PG // BETA 0.87